Excellent launches are winning the evidence battle
Beyond necessity and nice to have: RWE as a true strategic differentiator
White Paper
Mar 09, 2020

Launch Excellence has acquired an almost mythical quality: pursued by many, found by few, as we have observed in our most recent white paper on this topic. The pharmaceutical industry's quest for launch excellence has spurred a wealth of publications on how to achieve it, yet little has been written on the competitive use of real world evidence (RWE), as a true strategic differentiator, in the launch context.

In this white paper, we will explore the critical importance of RWE as a source of competitive advantage, how excellent launches have utilised it in achieving success and address key questions, such as: What is a competitive level of RWE? How early should RWE generation start? What issues should RWE focus on? And how do the answers to those questions change over the launch lifecycle?

You may also be interested in